The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 1 May 2025
- Planned end
- 30 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Medical management regimen
- Erector spinae plane (ESP) block
- Record updated
- 5 June 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients age between 18 and 75
- Patients with American Society of Anesthesiologists (ASA) II and III status
- Patients diagnosed with truncal chronic post herpetic neuralgia( neuropathic pain persistent for more than 3 months from the onset of rash appearance )
Who cannot take part
- Local infection in the site of the block
- Patients with impairment in hepatic (Alanine aminotransferase (ALT) >50 U/L, and/or Aspartate aminotransferase (AST): >45 U/L) or renal functions( creatinine level ≥1.5 mg/dL)
- Patients with coagulation abnormalities (i.e. international normalized ratio (INR) ≥1.5 and/or platelets ≤50000)
- Patients unable to comprehend the informed consent
- Patients on long term opioid regimens
- Patients on anti-coagulation regimens
- Patients with body mass index (BMI) > 35
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in Egypt.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To investigate the effectiveness of ultra-Sound guided Erector spinae block (ESB) with Betamethasone as an adjuvant to standard medical protocol in the management of truncal chronic post herpetic neuralgia.
The 2 groups in the trial
- Med groupExisting treatment, for comparison
Patients will receive the standard medical regimen alone.
Treatment: Medical management regimen
- Erector spinae plane block groupTreatment being tested
Patients will receive erector spinae plane (ESP) block with betamethasone with standard medical regimen.
Treatment: Erector spinae plane (ESP) block
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia, a Prospective Randomized Controlled Study.
- Criteria questions
- Built from NCT07000409, who can take part
- Record updated
- 5 June 2025